Kun-Ming Rau

Title: Kun-Ming Rau: Innovator in Cancer-Specific Therapeutics

Introduction

Kun-Ming Rau is a prominent inventor based in Niau-Sung Shiang, Taiwan. He has made significant contributions to the field of cancer research, particularly in the development of cancer-specific promoters. With a total of 2 patents, his work focuses on innovative therapeutic approaches for cancer treatment.

Latest Patents

Kun-Ming Rau's latest patents revolve around cancer-specific control sequences that direct the expression of polynucleotides encoding therapeutic gene products for cancer treatment. His inventions specifically target breast cancer, prostate cancer, and pancreatic cancer. Two of the breast cancer-specific sequences utilize specific regions of topoisomerase IIα and transferrin receptor promoters, particularly in combination with an enhancer. The prostate cancer-specific and pancreatic cancer-specific control sequences employ composites of tissue-specific control sequences, a two-step transcription amplification sequence, and a post-transcriptional control sequence. In more particular embodiments, these polynucleotides are administered in combination with liposomes.

Career Highlights

Kun-Ming Rau is affiliated with the University of Texas System, where he continues to advance his research in cancer therapeutics. His innovative work has garnered attention in the scientific community, contributing to the understanding and treatment of various cancers.

Collaborations

Some of his notable coworkers include Mien-Chie Hung and Chi-Ping Day, who have collaborated with him on various research projects.

Conclusion

Kun-Ming Rau's contributions to cancer research through his innovative patents highlight the importance of targeted therapies in the fight against cancer. His work continues to inspire advancements in the field of oncology.